Jiang‐Hui Zeng

703 total citations
31 papers, 505 citations indexed

About

Jiang‐Hui Zeng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Jiang‐Hui Zeng has authored 31 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Molecular Biology, 23 papers in Cancer Research and 8 papers in Surgery. Recurrent topics in Jiang‐Hui Zeng's work include Cancer-related molecular mechanisms research (18 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (10 papers). Jiang‐Hui Zeng is often cited by papers focused on Cancer-related molecular mechanisms research (18 papers), MicroRNA in disease regulation (10 papers) and RNA modifications and cancer (10 papers). Jiang‐Hui Zeng collaborates with scholars based in China and United States. Jiang‐Hui Zeng's co-authors include Gang Chen, Dianzhong Luo, Ruixue Tang, Rong‐Quan He, Liang Liang, Junqiang Chen, Jie Ma, Xiaoyong Cai, Shikang Li and Wenjie Chen and has published in prestigious journals such as PLoS ONE, Scientific Reports and BioMed Research International.

In The Last Decade

Jiang‐Hui Zeng

27 papers receiving 499 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jiang‐Hui Zeng China 14 360 353 122 64 46 31 505
Fangfeng Liu China 14 414 1.1× 386 1.1× 100 0.8× 86 1.3× 60 1.3× 26 552
Shaoqing Ju China 16 372 1.0× 402 1.1× 79 0.6× 91 1.4× 49 1.1× 29 555
Hai‐Liang Zhang China 10 319 0.9× 315 0.9× 132 1.1× 53 0.8× 33 0.7× 15 441
Yunong Fu China 12 358 1.0× 307 0.9× 118 1.0× 67 1.0× 34 0.7× 16 479
Heping Kan China 12 290 0.8× 221 0.6× 72 0.6× 89 1.4× 37 0.8× 18 425
Xiao Yu China 16 536 1.5× 361 1.0× 97 0.8× 59 0.9× 25 0.5× 32 646
Gao‐Min Liu China 9 267 0.7× 232 0.7× 163 1.3× 87 1.4× 35 0.8× 16 461
Fuchao Ma China 13 319 0.9× 223 0.6× 50 0.4× 60 0.9× 32 0.7× 25 407
Qiliang Peng China 13 260 0.7× 268 0.8× 93 0.8× 126 2.0× 43 0.9× 43 466
Wei‐Jia Mo China 12 272 0.8× 208 0.6× 76 0.6× 47 0.7× 28 0.6× 30 352

Countries citing papers authored by Jiang‐Hui Zeng

Since Specialization
Citations

This map shows the geographic impact of Jiang‐Hui Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jiang‐Hui Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jiang‐Hui Zeng more than expected).

Fields of papers citing papers by Jiang‐Hui Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jiang‐Hui Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jiang‐Hui Zeng. The network helps show where Jiang‐Hui Zeng may publish in the future.

Co-authorship network of co-authors of Jiang‐Hui Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Jiang‐Hui Zeng. A scholar is included among the top collaborators of Jiang‐Hui Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jiang‐Hui Zeng. Jiang‐Hui Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fang, Ye‐Ying, Dongming Li, Yu-Lu Tang, et al.. (2024). A Comprehensive Analysis of LYAR in Colorectal Cancer: Prognostic Marker and Therapeutic Target. Cancer Biotherapy and Radiopharmaceuticals. 39(9). 673–689.
3.
Lai, Chunhui, et al.. (2024). Effect of different delivery modes on intestinal microbiota and immune function of neonates. Scientific Reports. 14(1). 17452–17452. 7 indexed citations
6.
Tang, Wei, Jian‐Di Li, Rong‐Quan He, et al.. (2022). Downregulation of the enhancer of zeste homolog 1 transcriptional factor predicts poor prognosis of triple-negative breast cancer patients. PeerJ. 10. e13708–e13708. 4 indexed citations
7.
Chen, Gang, Jian‐Di Li, Zhi‐Guang Huang, et al.. (2022). Potential Molecular Mechanism of Upregulated Aryl Hydrocarbon Receptor Nuclear Translocator 2 in Nasopharyngeal Carcinoma. Computational and Mathematical Methods in Medicine. 2022. 1–20. 1 indexed citations
8.
Li, Guosheng, Rong‐Quan He, Jun Liu, et al.. (2022). Prognostic signature of esophageal adenocarcinoma based on pyroptosis-related genes. BMC Medical Genomics. 15(1). 50–50. 2 indexed citations
9.
He, Rong‐Quan, Zhi‐Guang Huang, Jie Li, et al.. (2022). Downregulated Dual-Specificity Protein Phosphatase 1 in Ovarian Carcinoma: A Comprehensive Study With Multiple Methods. Pathology & Oncology Research. 28. 1610404–1610404. 3 indexed citations
10.
Huang, Su-Ning, et al.. (2022). Upregulation of ITGAV and the underlying mechanisms in nasopharyngeal carcinoma. Electronic Journal of Biotechnology. 60. 43–57. 1 indexed citations
11.
Gao, Li, Rong‐Quan He, Zhi‐Guang Huang, et al.. (2022). Expression Landscape and Functional Roles of HOXA4 and HOXA5 in Lung Adenocarcinoma. International Journal of Medical Sciences. 19(3). 572–587. 6 indexed citations
12.
Chen, Gang, et al.. (2021). Down-Regulation of Activating Transcription Factor 3 (ATF3) in Hepatoblastoma and Its Relationship with Ferroptosis. International Journal of General Medicine. Volume 14. 9401–9418. 3 indexed citations
13.
Huang, Li, Yun Deng, Xu Zhu, et al.. (2020). Prognostic value of small nucleolar RNAs (snoRNAs) for colon adenocarcinoma based on RNA sequencing data. Pathology - Research and Practice. 216(6). 152937–152937. 20 indexed citations
14.
Zeng, Jiang‐Hui, et al.. (2019). Prognosis of clear cell renal cell carcinoma (ccRCC) based on a six-lncRNA-based risk score: an investigation based on RNA-sequencing data. Journal of Translational Medicine. 17(1). 281–281. 30 indexed citations
15.
Liang, Liang, Jiang‐Hui Zeng, Xin‐Gan Qin, et al.. (2018). Distinguishable Prognostic Signatures of Left- and Right-Sided Colon Cancer: a Study Based on Sequencing Data. Cellular Physiology and Biochemistry. 48(2). 475–490. 44 indexed citations
16.
Zeng, Jiang‐Hui, et al.. (2018). Oncogenic value of microRNA‑15b‑5p in hepatocellular carcinoma and a bioinformatics investigation. Oncology Letters. 17(2). 1695–1713. 18 indexed citations
17.
18.
Qin, Xin‐Gan, Jiang‐Hui Zeng, Peng Lin, et al.. (2018). Prognostic value of small nuclear RNAs (snRNAs) for digestive tract pan- adenocarcinomas identified by RNA sequencing data. Pathology - Research and Practice. 215(3). 414–426. 15 indexed citations
19.
Chen, Wenjie, Ruixue Tang, Rong‐Quan He, et al.. (2017). Clinical roles of the aberrantly expressed lncRNAs in lung squamous cell carcinoma: a study based on RNA-sequencing and microarray data mining. Oncotarget. 8(37). 61282–61304. 68 indexed citations
20.
Liang, Liang, Jiang‐Hui Zeng, Jieyu Wang, et al.. (2017). Down-regulation of miR-26a-5p in hepatocellular carcinoma: A qRT-PCR and bioinformatics study. Pathology - Research and Practice. 213(12). 1494–1509. 21 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026